Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
404-02-007 ISMRM Abstract

Relationships between key brain tumor metabolites in grade 2-3 astrocytoma and oligodendroglioma

Primary: Contrast Mechanisms - Spectroscopy
Secondary: Neuro - Tumors
404-02-007 · Altered Metabolism Across Healthy Aging and Neurological Disorders · Tuesday, 12 May, 8:20 AM–10:10 AM · Ballroom East
Keywords: Metabolism Glioma MR spectroscopy Glioma classification
Accepted
Dunja Simicic 1, Seyma Alcicek2,3, Lindsay Blair4,5, Max Saint-Germain4,6, Helge Zoellner1, Zsombor Ritter4,7, Jaishri O Blakeley5, Christopher W Davies-Jenkins1, Matthias Holdhoff4,5, John Laterra4,5, Chetan Bettegowda6, Karisa C Schreck4,5, Doris Lin1, Peter B Barker1,8, David O Kamson4,5, Georg Oeltzschner1
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, United States of America
2Goethe University Frankfurt, Department of Neuroradiology and Cooperative Brain Imaging Center - CoBIC, Frankfurt, Germany
3Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt, Germany
4Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, United States of America
5Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, United States of America
6Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, United States of America
7Department of Medical Imaging, University of Pécs, Pécs, Hungary
8F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, United States of America
Presenting Author: Dunja Simicic

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Picca A, Berzero G, Sanson M. Current therapeutic approaches to diffuse grade II and III gliomas. Ther Adv Neurol Disord. 2018;11:1756285617752039. doi:10.1177/1756285617752039 [doi]
2. Branzoli F, Liserre R, Deelchand DK, et al. Neurochemical Differences between 1p/19q Codeleted and Noncodeleted IDH-mutant Gliomas by in Vivo MR Spectroscopy. Radiology. 2023;308(3):e223255. doi:10.1148/radiol.223255 [doi]
3. Deluche E, Bessette B, Durand S, et al. CHI3L1, NTRK2, 1p/19q and IDH Status Predicts Prognosis in Glioma. Cancers. 2019;11(4):544. doi:10.3390/cancers11040544 [doi]
4. Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncol. 2021;23(8):1231-1251. doi:10.1093/neuonc/noab106 [doi]
5. Hvinden IC, Cadoux-Hudson T, Schofield CJ, McCullagh JSO. Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations. Cell Rep Med. 2021;2(12). doi:10.1016/j.xcrm.2021.100469 [doi]
6. Padelli F, Mazzi F, Erbetta A, et al. In vivo brain MR spectroscopy in gliomas: clinical and pre-clinical chances. Clin Transl Imaging. 2022;10(5):495-515. doi:10.1007/s40336-022-00502-y [doi]
7. Choi C, Ganji SK, DeBerardinis RJ, et al. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med. 2012;18(4):624-629. doi:10.1038/nm.2682 [doi]
8. Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ. 2-Hydroxyglutarate MR spectroscopy for prediction of isocitrate dehydrogenase mutant glioma: a systemic review and meta-analysis using individual patient data. Neuro-Oncol. 2018;20(12):1573-1583. doi:10.1093/neuonc/noy113 [doi]
9. Branzoli F, Di Stefano AL, Capelle L, et al. Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy. Neuro-Oncol. 2018;20(7):907-916. doi:10.1093/neuonc/nox214 [doi]
10. Branzoli F, Pontoizeau C, Tchara L, et al. Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy. Neuro-Oncol. 2019;21(6):765-774. doi:10.1093/neuonc/noz031 [doi]
11. Branzoli F, Deelchand DK, Sanson M, Lehéricy S, Marjańska M. In vivo 1H MRS detection of cystathionine in human brain tumors. doi:10.1002/mrm.27810 [doi]
12. Oeltzschner G, Zöllner HJ, Hui SCN, et al. Osprey: Open-source processing, reconstruction & estimation of magnetic resonance spectroscopy data. J Neurosci Methods. 2020;343:108827. doi:10.1016/j.jneumeth.2020.108827 [doi]
13. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30(6):672-679. doi:10.1002/mrm.1910300604 [doi]
14. Alcicek S, Simicic D, Blair L, et al. Pitfalls in 2HG detection with TE-optimized MRS at 3T. April 2025:2025.03.31.25324828. doi:10.1101/2025.03.31.25324828 [doi]
15. Kreis R. The trouble with quality filtering based on relative Cramér-Rao lower bounds. Magn Reson Med. 2016;75(1):15-18. doi:10.1002/mrm.25568 [doi]
16. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B Methodol. 1995;57(1):289-300. doi:10.1111/j.2517-6161.1995.tb02031.x [doi]
17. Berrington A, Voets NL, Plaha P, et al. Improved Localization for 2-Hydroxyglutarate Detection at 3 T Using Long-TE Semi-LASER. Tomography. 2016;2(2):94-105. doi:10.18383/j.tom.2016.00139 [doi]
18. Branzoli F, Deelchand DK, Liserre R, et al. The influence of cystathionine on neurochemical quantification in brain tumor in vivo MR spectroscopy. Magn Reson Med. 2022;88(2):537-545. doi:10.1002/mrm.29252 [doi]
19. Lee JE, Jeun SS, Kim SH, Yoo CY, Baek HM, Yang SH. Metabolic profiling of human gliomas assessed with NMR. J Clin Neurosci. 2019;68:275-280. doi:10.1016/j.jocn.2019.07.078 [doi]
20. Chen W, Lou H, Zhang H, et al. Grade classification of neuroepithelial tumors using high-resolution magic-angle spinning proton nuclear magnetic resonance spectroscopy and pattern recognition. Sci China Life Sci. 2011;54(7):606-616. doi:10.1007/s11427-011-4193-7 [doi]
21. Viswanath P, Radoul M, Izquierdo-Garcia JL, et al. Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner. Cancer Metab. 2018;6(1):3. doi:10.1186/s40170-018-0178-3 [doi]
22. Choi C, Ganji S, Hulsey K, et al. A comparative study of short- and long-TE 1H MRS at 3 T for in vivo detection of 2-hydroxyglutarate in brain tumors. NMR Biomed. 2013;26(10):1242-1250. doi:10.1002/nbm.2943 [doi]
23. Maddock RJ. Statistical non-independence of brain metabolite concentrations whether normalized to creatine or water. J Cereb Blood Flow Metab. 2025;45(1):196-198. doi:10.1177/0271678X241290018 [doi]
24. Maddock R. The Problem of Spurious Correlations Between Pairs of Brain Metabolite Values Measured in the Same Voxel With Magnetic Resonance Spectroscopy. JAMA Psychiatry. 2014;71(3):338-339. doi:10.1001/jamapsychiatry.2013.4343 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/404-02-007